Abstract
All breast lumps are considered to be carcinomas until proved otherwise and are acause of concern both for the patient and surgeon. The study was undertaken to knowthe histological spectrum of breast disease at B. P. Koirala Institute of Health Sciences(BPKIHS). BPKIHS is a recently started Medical University in the easternregion of Nepal. No data regarding breast diseases in this region is available as yet.152 breast tissues sent for histopathology from Jan. 96 - Dec. 98 were studied. Peakincidence of benign lesion was in 21 to 30 years and malignant lesions in 31 to 50years. No breast lesions were seen in the first decade of life. Cancer was seen in18.42% of cases. Fibroadenoma & Fibrocystic disease were the commonest benign &infiltrating duct carcinoma the commonest malignant lesion. Specimens from 10 malebreasts were received. Gynaecomastia was the commonest lesion in the males. Infiltratingduct carcinoma was seen in a 70 years male. Some uncommon breast lesionslike Syringocystadenoma & cysticercosis were also seen. In 3.28% of cases no lesionswere seen.Key Words: Breast, Fibroadenoma, Fibrocystic disease,carcinoma, Gynaecomastia.
Highlights
Breast lumps are a cause for concern both for the patient and surgeon because of the risk of cancer.Breast cancer is the commonest cancer in females in the developed countries
MATERIAL & METHODS: A retrospective analysis of breast tissue submitted for histopathology from 1st Jan. 96 to 31st Dec. 98 was done
2.3% of the total specimen received for histopathology
Summary
Breast lumps are a cause for concern both for the patient and surgeon because of the risk of cancer. All breast lumps are usually subjected to microscopic examination. The present study was undertaken to study the histomorphological spectrum of breast disease at BPKIHS. Address for correspondence : Dr Usha Rani Singh, Reader, Department of Pathology. No data regarding breast diseases in this region is available as yet
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
